CRNX
Crinetics Pharmaceuticals Inc
NASDAQ: CRNX · HEALTHCARE · BIOTECHNOLOGY
$38.78
+0.88% today
Updated 2026-04-30
Market cap
$3.99B
P/E ratio
—
P/S ratio
519.04x
EPS (TTM)
$-4.95
Dividend yield
—
52W range
$26 – $58
Volume
1.1M
Crinetics Pharmaceuticals Inc (CRNX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,170.00%
ROE
-40.20%
ROA
-25.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $589000.00 | $-6.02M | -765.87% | -1,026.15% | -1,021.90% |
| 2017 | $2.04M | $-9.16M | -351.49% | -446.31% | -447.78% |
| 2018 | $2.43M | $-27.11M | 100.00% | -1,182.45% | -1,116.76% |
| 2019 | $1.19M | $-49.53M | 100.00% | -4,512.32% | -4,152.14% |
| 2020 | $71000.00 | $-72.86M | 100.00% | -105,567.61% | -102,625.35% |
| 2021 | $1.08M | $-106.72M | 100.00% | -9,990.91% | -9,899.72% |
| 2022 | $4.74M | $-159.95M | 100.00% | -3,544.06% | -3,376.69% |
| 2023 | $4.01M | $-214.53M | 100.00% | -5,547.17% | -5,345.85% |
| 2024 | $1.04M | $-298.41M | 100.00% | -32,613.47% | -28,720.69% |
| 2025 | $7.70M | $-465.32M | 35.47% | -6,714.77% | -6,046.22% |